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Mac-2 is a 32-kD murine macrophage cell surface protein first identified by Ho
and Springer (1) . In their original characterization of the antigen, they found that
it was expressed on thioglycollate-elicited peritoneal macrophages at a much higher
level thanon othermacrophages, and they suggested that it might be a subpopulation-
specific marker . Subsequent work has demonstrated that the Mac-2 antigen is ex-
pressed to varying degrees inmostmacrophage populations, macrophage cell lines,
interdigitating dendritic cells in various lymphoid organs, and in some epithelial
cells (2, 3) . Surface immunofluorescence studies indicate that the level ofMac-2 ex-
pression increases during the maturation ofmacrophage precursors, but that there
is heterogeneity in expression among different macrophage subpopulations and in
different macrophage cell lines (2, 4). It is not clear whether this variation correlates
with differences in function . The elevated expression ofMac-2on macrophages elicited
by an inflammatory stimulus suggests that it may be involved in the recruitment
of a specific subpopulation of macrophages to the site of inflammation or that it
is induced during the process of activation by the inflammatory stimulus.
Despite these indications that the Mac-2 antigen may play an important role in
macrophage biology, little is known about its structure and function . To learn more
about this molecule, and as a part of our attempts to understand the early events
in the inflammatory activation of macrophages, we have cloned cDNAs encoding
the Mac-2 antigen by immunoscreening ofamacrophage cDNA expression library.
In the present report, we show that the nucleotide sequence ofthe Mac-2 cDNAs,
apart from a short stretch at their 5' ends, is identical to that ofcarbohydrate binding
protein 35 (CBP35)', a galactose-specific lectin found in fibroblasts (5) and highly
homologous to that of a rat IgE-binding protein (rIgEBP), originally described in
a rat basophilic leukemia cell line (6). Furthermore, the in vitro synthesized Mac-2
protein binds to carbohydrate determinants on asialofetuin, a desialylated glycopro-
tein, and to IgE . The sequence ofthe Mac-2 cDNAs, like that ofCBP35 and rIgEBP,
does not contain a classical signal peptide ortransmembrane domain . This finding
is consistent with the intracellular location of the latter two proteins (7, 8); however,
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it is at odds with our observation that the Mac-2 protein, in addition to being present
in the cytosol, is also secreted into the extracellular medium, and with the observa-
tions of several other groups that have demonstrated Mac-2 on the cell surface (2, 4).
These data raise questions regarding the function of the carbohydrate and IgE-
binding properties of Mac-2 in inflammatory macrophages, and about the mecha-
nism by which this protein reaches the cell surface.
Materials and Methods
Molecular Cloning ofthe Mac-2 cDNA.
￿
A Xgtll-P388D1 expression library was obtained from
R. A. B. Ezekowitz, Children's Hospital, Boston, MA. It was screened by the method ofSnyder
et al. (9), using M3/38, a rat mAb to the Mac-2 antigen (Boehringer Mannheim Biochem-
icals, Indianapolis, IN). A rabbit anti-rat antiserum (Zymed Laboratories, San Francisco,
CA) followed by goat anti-rabbit antibody coupled to alkaline phosphatase (PromegaBiotec,
Madison, WI) was used as the detection system. 3 of the 10 positive plaques were purified,
and the cloned phage (Mac 2 .3, Mac 2.9, and Mac 2.10) were used to prepare DNA and
lysates containing fusion protein (9). The lysates were subjected to Western blot analysis (10)
using M3/38 and an isotype-identical control antibody to probe the blot. The bound anti-
body was detected using the enzyme-linked detection system described above. The insert
DNAs from the Xgtll clones were subcloned into the vector pBSK (Stratagene, LaJolla, CA).
A radiolabeled (11) probe made from the insert DNA of Mac 2.3 was used to rescreen the
library (12). Positive plaques were purified and the longest insert (from clone Mac 2.16) was
subcloned into pBSK. Restriction maps of all pBSK clones were constructed and further sub-
clones made so as to allow sequencing of both strands over the full length of the original
inserts. Double-stranded sequencingwas carried out with a kit from Boehringer Mannheim
Biochemicals, using commercially available T3 and T7 primers (Stratagene).
Northern Hybridization Analysis.
￿
Total cellular RNA from various cells and cell lines was
prepared by the guanidinium isothiocyanate method (13). The cell linesused wereJ774 and
P388D1(macrophage), A20.25 (B cell), EL4 (thymoma), 70Z/3(pre-B cell), Swiss 3T3 (fibro-
blast) (all obtained from the American Type Culture Collection, Rockville, MD), and AJ9
(B cell; reference 14). 30 gg ofeach sample was subjected to electrophoresis on a 1.2 % formal-
dehyde agarose gel, transferred to nitrocellulose, and hybridized as described (12), usingthe
radiolabeled (11) insert from Mac-2.16 as a probe. After washing, the filter was exposed for
autoradiography.
In Vitro Transcription and Translation.
￿
Capped mRNAwas synthesized in vitro from Mac-2
cDNA templates cloned in pBSK using the mCAP kit from Stratagene. In vitro translation
of the RNA was then carried out using rabbit reticulocyte lysate (Stratagene), following the
manufacturer's instructions.
Binding to Immobilized IgE and Asialofetuin.
￿
IgE (monoclonal mouse IgE anti-DNP; ICN
Immunobiologicals, Lisle, IL), IgG, and IgM (Zymed Laboratories) were coupled to Sepharose
CL-4B (Pharmacia Fine Chemicals, Piscataway, NJ) at concentrations of 1 mg/ml packed
beads, and asialofetuin (Sigma Chemical Co., St. Louis, MO) was coupled at a concentration
of 10 mg/ml packed beads(15). Equal aliquots ofthe in vitrotranslation products were diluted
in 1 ml of lysis buffer, i.e., 0.5% Triton X-100 in reticulocyte saline buffer (RSB; 10 mmol
Tris-Cl, pH 7.4, 3 mmol MgC12, 10 mmol NaCl) containing 2 mmol PMSF and mixed with
150 pl ofa 50% slurry of the immobilized ligand in PBS. For competitions, the in vitro trans-
lated product was mixed with 1 ml oflysisbuffer containing the competing sugar (galactose,
glucose, lactose, or maltose) at a final concentration of 100 mmol, just before addition of
the immobilizedligand. N-glycanase treatment ofthe IgE-Sepharose and asialofetuin-Sepharose
was carried out at 37°C overnight using 0.25 U of enzyme (Genzyme, Boston, MA) per 150
pl of a 50% slurry of the immobilized ligand (16). Mock digestion was carried out in buffer
without enzyme. After binding to the translated protein overnight at 4°C, the Sepharose
beads were washed five times with wash buffer (50 mmol Tris-Cl, pH 8.2, 500 mmol NaCl,
5 mmol EDTA, 0.02% NaN3, 0.5% Triton X-100, 0.5% sodium deoxycholate, 0.1% SDS)
and then boiled for 3 min in 50 p,l of 2 x SDS-PAGE sample buffer (125 mmol Tris-Cl, pHCHERAYIL ET AL.
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6.8, 4% SDS, 20% glycerol, 10% 2-ME, 0.002% bromophenol blue). The released material
was analyzed by SDS-PAGE.
LabelingofMacmphagerandImrnunoprecipitattons.
￿
Inflammatory peritoneal macrophages were
harvested by lavage with PBS from DBA/2 or BALB/c mice on the fourth day after in-
traperitoneal injection of1.5 ml ofsterile 3% brewer's thioglycollate (Difco Laboratories Inc.,
Detroit, MI), prepared according to manufacturer's instructions. Equal numbers ofthe exu-
date cells were distributed into 35-mm plastic tissue culture dishes (Corning Glass Works,
Corning, NY) and allowed to adhere for 2 h at 37°C. After washing off nonadherent cells,
the adherent cells were incubated in 1 ml of DME lacking methionine for 1 h at 37°C and
then labeled with ["S]methionine (250 pXi/ml) for l h. At the end of the labeling period,
the medium was removed, the cells were washed three times with ice-cold PBS, and then
lysed in 1 ml of ice-cold lysisbuffer containing2 mmol PMSF For the pulse-chase analysis,
the cells were labeled for 1 h as above. After removing the medium and washing the cells,
they were chased at 37°C in 4 ml/well of medium supplemented with 2 mmol methionine
for different periods of time. At the end of the chase period, the wells were quickly chilled
on ice, and the medium was collected and saved. The cells were then washed with 0.5 ml
of ice-cold PBS, and the wash was added to the medium. The cells were lysed as described
above. After the medium was centrifuged to remove contaminating cells, PMSF was added
to a finalconcentration of 2 mmol and Triton X-100was added to a finalconcentration of0.5%.
Cell lysates were centrifuged at 600 g for 5 min to remove nuclei and then at 10,000 g for
20 min. They were then precleared overnight at 4°C with 2 hg ofrabbit IgG (Zymed Labora-
tories) and 150 141 of a 3% slurry of protein A-Sepharose (Pharmacia Fine Chemicals) in
PBS. Immunoprecipitations were carried out by adding 2 wg of M3/38 followed by 2 pg of
rabbit anti-rat antiserum and 150 id ofprotein A-Sepharose to the precleared lysate. Control
immunoprecipitations used an isotype-identical rat mAb to IgM (Zymed Laboratories) in
place ofM3/38. Aliquots of the extracellular medium were precleared and immunoprecipi-
tated in exactly the same way. As a control to check for passive leakage ofcytosolic proteins
into the extracellular medium, aliquots of the medium were immunoprecipitated with an
antiactin antibody (Sigma Chemical Co.). After binding overnight at 4°C, the Sepharose
beads were washed five times with wash buffer and then resuspended and boiled for 3 min
in 50 ul of 2 x SDS-PAGE sample buffer. Aliquots of the released material were analyzed
by SDS-PAGE.
Subcellular Fractionation.
￿
Monolayers of thioglycollate-elicited macrophages were labeled
and chased for 3 h as described above. At the end of the labeling period, the cells were washed
with PBS and then with 0.3 x RSB. The cells were then scraped with a rubber policeman
into 1 ml of 0.3x RSB containing 2 mmol PMSF and then homogenized in a Dounce
homogenizer. After spinning out the nuclei at 600 g for 5 min, the lysate was centrifuged
at 400,000 g for 15 min in a TLA 100 rotor (Beckman Instruments, Inc., Palo Alto, CA).
The supernatant was saved as the cytosolic fraction. The membrane pellet was washed once
with 1 x RSB and the wash was pooled with the cytosol. The final pellet was extracted in
lysis buffer and, afterspinning out insoluble material, the supernatant was saved as the mem-
brane fraction. The cytosolic fraction was made up to the same detergent and salt concentra-
tions as the membrane fraction before both fractions were immunoprecipitated. The validity
of the fractionation protocol was checked by immunoprecipitating aliquots of the fractions
with Ml/70, a mAb to Mac-1, a known macrophage plasma membrane antigen (17).
SI Nuckase Protection Analysis.
￿
The protocol used has been described previously (12). 5'
end-labeled, double-stranded probes that encompassed the 5' ends of the cDNA were made
from the Xba I-Xho I fragments of the pBSK clones Mac-2.16 and Mac-2.9 (see Figs. 1 A
and 7 A). 40,000 cpm of the probe were hybridized with 10-20,ug of total cellular RNA or
with tRNA (as a control) at 60°C overnight. Digestion with S1 nuclease (New England Bi-
olabs, Beverly, MA), 400 U/ml, was carried out for 90 min at room temperature. The prod-
ucts were then analyzed on a 7 M urea/5% polyacrylamide gel.
AnchoredfblymeraseChain Reaction (PCR).
￿
The protocol used was basedon published proce-
dures (18, 19). A 20-nucleotide oligomer (5' CCCTGCCCCAGGCTGGTTCC 3') designed
to hybridize to Mac-2 mRNA 32 nucleotides downstream ofthe Eco RV site (Fig. 1 A) was
used to prime first strand cDNA synthesis towards the 5' end of the mRNA using 5 ,ug of1962
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total cellular RNA from thioglycollate-elicited macrophages. A poly-G tail was then added
to the Tend ofthe cDNA. Amplification ofthe cDNA wasthen carried out using two oligonu-
cleotide primers. A 28-nucleotide oligomer (5' GGCCCATGCGGCCGCCCCCCCCC-
CCCCC 3) that was complementary to the poly-G tail and contained a Not I restriction
site allowed DNA synthesis to occurtowards the 3' end of the mRNA. Synthesis in the reverse
direction was achieved with an 18-nucleotide oligomer (5' ACCCGGATATCCTTGAGG 3')
containing the Eco RV site (Fig. 1 A). The conditions of amplification were as follows: melting
at 94°C for 1 min, annealing at 50°C for 2 min, and extension at 72°C for 3 min. After
40 cycles of amplification, the DNA product was cut with Not I and Eco RV, and analyzed
on a 1% agarose gel. A -150-bp band was visualized by ethidium bromide staining. This
band was confirmed to be the specific amplification product by Southern analysis with a Mac-
2 probe. It was isolated, cloned in pBSK, and sequenced.
SDS-PAGE.
￿
12% polyacrylamide gels containing 0.1% SDS were used in all experiments
and were run under standard conditions (20). After electrophoresis, gels (other than those
used for Western analysis) were soaked in Autofluor (National Diagnostics, Inc., Somerville,
NJ), dried, and exposed for autoradiography.
Results
Molecular CloningoftheMac-2 cDNA.
￿
Weused themAb M3/38to clone theMac-2
cDNA from a Xgtll-P388D1 expression library. 10 positive clones were obtained,
ofwhich three (Mac-2 .3, Mac-2.9, and Mac-2.10) were purified. Lysogens ofthese
three clones produced fusion proteins (with a molecular mass of -150 kD in the
case ofMac-2.3 and Mac-2.10, and -135 kD in the case ofMac-2.9), which reacted
on Western analysis with the ant-Mac-2 antibody M3/38, but not with an isotype-
identicalcontrolantibody (datanot shown). After subcloning theinsert DNAs (sized
940, 570, and940bp, respectively) ofthe three clones into the Eco RI siteofpBSK,
restriction maps were constructed andareshowninFig. 1 A. Byrestriction mapping
andby subsequent sequence analysis, Mac-2.3 and Mac-2.10 were foundtobeiden-
tical. The insert DNA from Mac-2.3 was used to rescreen the library by DNA hy-
bridization and, in this fashion, a clone with a slightly longer insert (970 bp) was
obtained (Mac-2.16) (Fig. 1 A). The sequenceofMac-2.16containedan openreading
frame encoding a protein ofpredicted molecular mass of27,482 daltons, consistent
with the size ofthe Mac-2 protein on SDS-PAGE. The amino acid sequence con-
sisted oftwo domains: an NH2-terminal domain containing a repetitive proline and
glycine-rich motif, and a C0011-terminal domain containing the amino acid se-
quence HFNPRF . . . WGXEXR (where the letters represent the standard one-
letter amino acid code, Xbeing any amino acid) found in S-type lectins (21). There
were no potential N-glycosylation sites. When the sequence of the Mac-2 cDNA
was compared with those in existing databases, it was found to be identical to that
FIGURE 1.
￿
(A)Restriction maps ofthe insert DNAs oftheclones Mac-2.16, Mac-2.9,and Mac-
2.3 in the vector pBSK. The lengths of the inserts of these clones are -970, -570, and -940
bp, respectively. The scale is indicated by the 100-bp bar. (B) The nucleotide sequences of the
5' ends ofMac-2cDNAs. Mac-2.16, Mac-2.9,andMac-2.3 areXgtll clones, andpBC7 andpBC12
are clones obtained by PCR, pBC7 being the 5' extension of Mac-2.16, and pBC12 being the
5' extensionof Mac-2.9 andMac-2.3. Thenumbersbelowthesequence indicate nucleotide posi-
tions. Thepredictedaminoacid sequence is indicatedabovethenucleotide sequence in thestan-
dard three-letter code. Stop, an in-frame stop codon. The underlined nucleotides in Mac-2.16
and pBC12 constitute the 27-bp sequence not found in Mac-2.9, Mac-2.3, and pBC7. These
sequence data have been submitted to the EMBL/GenBank Data Libraries underthe accession
number X16834.A
￿
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of the cDNA for a known galactose-specific S-type lectin, CBP35, and highly ho-
mologous to the cDNA for rIgEBP Our sequence extended a little more 5' than
the published sequences ofCBP35 and rIgEBP, and included an ATG start codon
andan in-frame stop codonupstream of it (Mac-2.16; only the 5'endof thesequence
is shown, the complete sequence can be found in reference 5 and a comparison of
CBP35 and rIgEBP in reference 22 ; Fig . 1 B) . The predicted second amino acid
ofour sequence differs from thecorresponding one ofCBP35;thedifference is prob-
ably attributable to a minor sequencing error. The nucleotide context of the puta-
tive start codon fits the Kozakconsensus (23) in having an A residue at the -3 posi-
tion and a G residue at the +4 position . To further confirm that we had indeed
cloned theMac-2 cDNA, the in vitro synthesized product ofourclonewasimmuno-
precipitated with M3/38 . Fig . 2, lane 2, shows that the in vitro synthesized protein
is specifically immunoprecipitated byM3/38 (and not by the control antibody ; lane
1) andfurthermore, comigrates precisely with the Mac-2 antigenexpressedbymac-
rophages (lane 3) . We used the Mac-2 cDNA to asssess its expression in various
tissues and cell lines by Northern analysis. Fig. 3 shows that a -1.2-kb transcript
is identified by the Mac-2 probe . It is most highly expressed in thioglycollate-elicited
macrophagesand at moderate levels in the macrophage cell linesJ774 and P388D1 .
It is also expressed at a low level in Swiss 3T3 fibroblasts and at a very low level
in resident peritoneal macrophages (data not shown) . There was no evidence of ex-
pression in any of the lymphoid lines examined, even on prolonged exposure of the
filter, consistent with thepresumed absence ofthe Mac-2 protein in lymphocytes(3) .
TheMac-2ProteinBinds to CarbohydrateDeterminants and to IgE.
￿
In view of the prop-
erties suggested by its sequence, we tested the carbohydrate- and IgE-bindingprop-
erties of the in vitro synthesized Mac-2 protein using the desialylated glycoprotein
asialofetuin, and IgE, IgG, and IgM, all coupled to Sepharose, as ligands . Fig. 4,
lanes 1-5, show that asialofetuin binds to the Mac-2 protein and that galactose and
the galactose-containing disaccharide lactose inhibit this binding, whereas glucose
andmaltose do not . Treatment of asialofetuin with N-glycanase to remove N-linked
sugar residues completely abolishes its binding to the Mac-2 protein (Fig . 4, lanes
6 and 7) . These findings suggest that Mac-2 binds to galactose-containing deter-
FIGURE 2 .
￿
Autoradiograph of SDS-PAGE of immunoprecipitations of [35S]methionine-labeled in vitro synthesized Mac-2 protein (lanes 1 and
2) and lysates ofthioglycollate-elicited macrophages (lanes 3and 4) . The
anti-Mac-2 antibody M3/38wasused for the immunoprecipitations shown
in lanes 2 and 3, and an isotype-identical control antibody to IgM for
those in lanes 1 and 4 . The numbers on the left of the figure indicate
molecular mass in kilodaltons .CHERAYIL ET AL.
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FIGURE 3 .
￿
Expression ofMac-2
in various cell lines by Northern
analysis. Lane 1, J774 ; lane 2,
P388D1; lane 3, thioglycollate-
elicited macrophages ; lane 4,
70Z13; lane 5, AJ9; lane 6,
A20.25; lane 7, EL4 ; lane 8,
Swiss3T3 fibroblasts. (Top)The
results ofprobing withtheMac-
2 cDNA ; (bottom) the results
after stripping the filter and
reprobing with a tubulin probe.
minants on the ligand. IgE also binds to Mac-2 and this interaction is inhibited
by galactose and lactose (Fig. 4, lanes 8-12) . This binding is IgE specific, since it
is not displayed by IgG or IgM and is not abolished by treating the IgE-Sepharose
with N-glycanase (datanot shown) . The latter finding suggests that if sugar residues
on IgE are involved in binding to Mac-2, they may be O-linked .
Mac-2 Is Present in the Cytosol, in the Extracellular Medium, and in the Membrane Frac-
tion . The results ofinitial experiments aimed at determining the subcellular loca-
tion of the Mac-2 protein indicated that the protein was present in the extracellular
medium as well as the cytosol . We then carried out a formal pulse-chase analysis,
whichshowed that the amount ofMac-2in the extracellularmedium increased steadily
with time up to 3 h (Fig . 5, top) . Actin could not be detected in the medium at any
time point, indicating that significant leakage of cytosolic proteins did not occur
during the course oftheexperiment (data not shown). Though the amount ofMac-2
associated with the cell did not change dramatically with time, a slight decrease was
discernible between 30 and 180 min (Fig. 5, bottom) . When cells were fractionated
into cytosolic and membrane fractions at the end of 3h of chase, Mac-2 was found
in both the cytosolic andmembrane fractions, in approximately equalamounts (Figure
6, top) . The latter could represent protein in transit to the extracellular medium or
protein bound to the plasma membrane (see Discussion) .
An Alternatively Spliced Mac-2 cDNA .
￿
In view of the fact that Mac-2 was appar-
FIGURE 4 .
￿
Autoradiograph of
SDS-PAGE ofprecipitations of
in vitro synthesized Mac-2 pro-
tein using immobilized ligand .
Lane l, asialofetuin-Sepharose ;
lane 2, asialofetuin- Sepharose
plus 100 mmol galactose ; lane
3, asialofetuin-Sepharose plus
100mmol glucose ; lane 4, asialofetuin-Sepharose plus 100mmol lactose; lane 5, asialofetuin-Sepharose
plus 100mmol maltose; lane6, mock-treated asialofetuin-Sepharose ; lane 7, N-glycanase-treated asialofetuin-
Sepharose; lane 8, IgE-Sepharose; lane 9, IgE-Sepharose plus 100mmol galactose; lane 10, IgE-Sepharose
plus 100 mmol glucose; lane 11, IgE-Sepharose plus 100 mmol lactose; lane 12, IgE-Sepharose plus 100
mmol maltose. The numbers on the left of the figure indicate molecular mass in kilodaltons.1966
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FIGtRLE 5 .
￿
Autoradiograph of SDS-PAGE ofthe pulse-chase anal-
ysis of the Mac-2 protein in thioglywllate-elicited macrophages. The
figure shows immunoprecipitations of the culture supernatant (top)
or cell lysates (bottom) with the anti-Mac-2 antibody at 5, 30, 90, and
180 min of chase .
ently secreted into the medium, it was surprising to find that the Mac-2 cDNA did
not encode a signal peptide (24), even though there are a few extracellular proteins
that lack such a sequence (25, 26). Sincewe knew thatMac-2 was probably encoded
by a single gene (J . Michaelson and M . Hanson, unpublished observations), we
considered the possibility that an alternatively spliced cDNA might give rise to a
signal peptide-containingprotein . Two ofthe clones that we originally isolated from
the Agt11-P388D1 library, Mac-2.9 and Mac-2.3, did in fact differ at their 5' ends
from Mac-2.16 (Fig. 1 B), though the rest of the sequence of the three clones was
identical . To verify that this difference was not the result of a cloning artifact, we
carried out an S1 nuclease protection analysis, using total cellularRNAand double-
stranded end-labeled probes made from Mac-2.9 and Mac-2.16 (Fig. 7 A) . Fig . 7
B shows the results of this experiment ; lanes 5 and 10 show the 537-bp Mac-2.9
probe and the 558-bp Mac-2.16 probe, respectively, each corresponding to the Xho
I-Xba I fragments shown in Fig. 7A . Lanes 4 and 9 show the probes after digestion
with Eco RI, which results in the 507-bp RI-Xba I fragment of Mac-2 .9 and the
528-bp RI-Xba I fragment of Mac-2.16 . Since the Xho I-R I fragments of each
probe are derived from vector DNA, the RI-Xba I fragments represent the size of
the full-length protected probe. Lanes 3and 8show that thioglycollate-elicited mac-
rophages contain mRNA, which confers full-length protection on both the Mac-2.9
FiouRE 6 . Autoradiograph of SDS-PAGE of sub-cellular fractions of
thioglyoollate-elicited macrophages. The figure shows immunoprecipitations
ofthe cytosolic and membrane fractions with the anti-Mac-2 antibody (top)
or the anti-Mac-1 antibody (bottom) .CHERAYIL ET AL .
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FIGURE 7 .
￿
(A) Probes used for
the Sl nuclease protection anal-
ysis . The probes were derived
from the pBSK clones of Mac-
2.16and Mac-2.9 (see Fig. 1 A).
Rl refers to Eco RI. (B) Sl
nucease protection analysis using
Mac-2probes and total cellular
RNA. Lanes 1 and 6, tRNA;
lanes2and 7, A20.25 ; lanes3
and 8, thioglycollate-elicitedma-
crophages ; lanes 4 and 9, Eco
Rl cut probe ; lanes 5 and 10,
uncut probe. Lanes 1-5, Mac-
2.9 probe ; lanes 6-10, Mac-2.16
probe. Expected sizes ofprotected
fragments : Mac-2.9, full-length
protection, 507bp; partial pro-
tection, 494bp ; Mac-2.16, full-
length protection, 528bp; par-
tial protection, 494 bp.
andthe Mac-2.16 probes . In addition to the fullyprotected fragments, shorter frag-
ments representing partialprotection ofthe probes are also seen . Lanes 1, 2, 6, and
7are controls that indicate that the protected fragments are specific toRNA from
macrophages . The fact that full-length protection ofboth probes is obtained strongly
suggests that both Mac-2 .9 and Mac-2 .16 are authentic cDNAs derived from two
distinct mRNAs present in macrophages. The presence ofone fragment of 494 bp,
representing partial protection of each ofthe twoprobes, is acorollary to this finding.
The presence ofmore than one partially protected fragment (seen clearly in Fig .
7, lane 8) may indicate the existence of other Mac-2 transcripts that we have not
yet identified as cDNA clones .
We obtained further 5' sequence for both Mac-2.9 and Mac-2.16 using the an-
chored PCR technique . The sequence of the two clones thus obtained are shown
in Fig. 1 B, pBC7 being the 5' extension ofMac-2.16, and pBC12 being the 5' exten-
sion ofMac-2.9 . Inspection ofthe sequences in Fig. 1 B indicates that the two types
of clones are identical, except for a 27-bp insertion in Mac-2.16 and pBC7 (under-
lined in Fig. 1), which introduces an in-frame stop codon upstream of the initiator
methionine codon . The 27-bp insert starts with GT, suggesting that it might repre-
sent an intron that is spliced out in the second type ofclone (Mac-2.9 and pBC12) .
The 27-bp insert is too short to be an entire intron (27) . It is theoretically possible
that it might represent a partially deleted intron and that Mac-2.16 is, therefore,1968
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an unsplicedprecursorofMac-2.9 and Mac-2.3. This seems unlikely fortwo reasons.
First, it is unlikely that identical deletions occurred independently during genera-
tion of the cDNA library as well as during the anchored PCR reaction. Second,
the relative abundance ofthe fully protected species in the S1 nuclease protection
experiment (Fig. 7 B, lane 8) when using a probe that completely spans the 27-bp
insert strongly suggests thatthe insert cannot be a partiallydeletedintron, even though
total cellular RNA was used for the analysis. Mac-2.16 must, therefore, be an alter-
natively spliced form of Mac-2.9 and Mac-2.3. Adetailed analysis ofthe genomic
region encoding thesecDNAs wouldprovidethemostreliable confirmation ofthese
predicted splicing events. In the type ofcDNA represented by Mac-2.3, Mac-2.9,
and pBC12, the alternative splicing event results in the open reading frame being
continued upstream ofthe initiation codon tillthe stop codon atposition -69. There
are no ATGs in this 5' extension of the reading frame. However, there is a CTG
codon at position -42 and CTGs have been reported to act as initiation codons
in at least two other proteins in vivo and in one in vitro system (28-30). After the
CTG codon, the sequence has the potential to encode a stretch ofuncharged, pre-
dominantly hydrophobic amino acids that resembles a signal peptide.
Discussion
The most significant finding ofthe present study is that the cDNA sequence en-
coding the Mac-2 antigen, a protein that is highly expressed in inflammatory mac-
rophages, is identical to that ofCBP35, a galactose-specific $-type lectin found in
murine fibroblasts (5), andhighly homologous tothatofrIgEBP, originally described
in a rat basophilic leukemia cell line (6). Based on this information, we were able
todemonstrate thatthe invitro synthesized Mac-2 proteinhadthe expected galactose-
specific carbohydrate-binding activity as well as specific IgE-binding activity. Our
dataindicatethat the bindingto IgE isinhibited bygalactoseand lactose, suggesting
that it involves the carbohydrate-binding siteofthe Mac-2 protein; however, wecannot
rule out the possibility that Mac-2 also has a separate IgE-binding site. It is of in-
terest inthis connection thatthelowaffinityIgE receptor ishomologous toa galactose-
specific lectin (31), although the role ofthe lectin domain in IgE binding has not
been elucidated.
CBP35 and rIgEBP are presumed to be intracellular proteins (7, 8). Our data
indicate that even though a large proportion ofthe Mac-2 protein is present in the
cytosol, a significant amount is also present in the extracellular medium. It is not
clear howthe protein reaches the latter site since the cDNA sequence ones not con-
tainaclassical signal peptide. This situation is notunique toMac-2, however. Other
S-type lectins and two other proteins, IL-1 and fibroblast growth factor, also share
this property ofbeing foundinthe extracellularmedium and yet nothaving asignal
peptide (21, 25, 26). As has been suggested in these cases, it is possible that Mac-2
reaches the exterior either by passive release from lysed cellsor byaprocessofactive
secretion that does not require a signal peptide. In this connection, it is interesting
thatwehavebeen ableto demonstrate theexistenceoftwo alternatively spliced Mac-2
cDNAs, one of which has the potential to encode a colinear, NH2 terminally ex-
tended Mac-2 protein containing a signal peptide-like sequence initiating with a
CTG codon. Genomic clones ofthe Mac-2 gene are being analyzed to confirm the
structural basisfor the predictedsplicing event and experiments todeterminewhetherCHERAYIL ET AL.
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the alternative splicing is in any way related to the existence ofcytosolic and ex-
tracellular Mac-2 are currently in progress.
The Mac-2 antigen was originally described byHo and Springer (1) as acell sur-
face protein based on immunofluorescence, cell surface iodination, and binding of
antibody to intact cells. Based on theirdata, they calculated that there were 1.7-3.4
x 105 surface molecules of Mac-2 per cell, making it a major surface component
ofthioglycollate-elicited macrophages. Immunofluorescence studies from anumber
ofgroups are consistent with surface expression of Mac-2 on macrophages (2, 4).
The cDNA sequence suggests that Mac-2 is notatransmembrane protein. The most
likely explanationforits beingdetected onthecell surfaceisthat someofthe protein
that is released extracellularly binds to exposed galactoseresidues on plasma mem-
brane glycoproteins or glycolipids. Preliminary experiments from our laboratory
indicate that Mac-2 does indeed bind to a surface protein in macrophages. IfMac-
2, like most other animal lectins (21), is multivalent, membrane-bound Mac-2would
still be able to bind external ligands and would, in effect, act as a surface receptor.
An analogous process may explain the presence of a small proportion ofrIgEBP
on the surface of rat basophilic leukemia cells (8).
Theidentification ofMac-2 as alectin provides some clues to its possible function
in macrophage biology. Several recent reports have documented the lectin-like prop-
erties ofadhesion molecules involved in leukocyte homing (32). An analogous func-
tion may be considered for Mac-2, especially in view ofthe fact that thioglycollate-
induced inflammation appears to selectively recruit macrophages with a high level
of Mac-2 expression. A number of macrophage lectins have also been described,
namely, amannose-fucose receptor on alveolarmacrophages (33), agalactose-fucose
receptor on Kupffer cells (34), and a sialic acid receptor on stromal tissue macro-
phages (35). A galactose-specific lectin on rat Kupffercells has also been described
that, interestingly enough, has a molecular mass of30 kD (36). It is possible that
Mac-2 is the murine homologue of this protein. The mannose-fucose receptor is
one ofthe best studied of these lectins and has been shown to be involved in the
binding and phagocytosis ofleishmania (37) and possibly mycobacteria. It is likely
that suchlectin-mediated phagocytosis would require thecooperativeaction ofmul-
tiple lectins of different specificity so as to engage different sugar determinants on
the surface ofthephagocytosed particle. Thus, galactose-specific lectins such asMac-2
could contribute to such a process. One ofthe major surface determinants of the
intracellular pathogen Leishmania major is a galactose-rich lipophosphoglycan that
has been shown to be involved in the binding of this parasite to the macrophage
(38, 39). Since this binding is competed by galactose, Mac-2 is a likely candidate
as a receptor for this parasite glycoconjugate.
Thehuman mannose-specific lectin, mannose-bindingprotein (MBP), is secreted
by hepatocytes and is present in the serum at high levels after stress (40). Several
functions ofthis protein have been recently demonstrated. It acts as an opsonin by
binding to bacteria with high mannose surface determinants and facilitating their
phagocytosis by macrophages (41). It has been shown to bind to gp120 ofHIV and
interfere with its binding to CD4 (42). Finally, a related rat mannose-binding pro-
teinhas been shownto activate complement through theclassicalpathway(43). The
structure ofMac-2 resembles that of MBP in some ways: both are -30 kD in size
and both have a COOH-terminal lectin domain and an NH2-terminal domain with1970
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a repetitive proline- and glycine-rich structure. Given this structural similarity, it
is possible that Mac-2 will also share some of the functional properties of MBP.
Lymphocyte-derived IgE-binding factors have been described that are believed
to be involved in the regulation of IgE expression (44). The IgE-binding property
ofMac-2 raises the possibility that it may have similar functions and may implicate
the macrophage in such regulatory processes. These and the other putative func-
tions discussed can now be analyzed rigorously using the cloned Mac-2 molecule.
Summary
A cDNA encoding the Mac-2 antigen, a surface marker highly expressed by
thioglycollate-elicited macrophages, has been cloned by immunoscreening ofa Xgtll-
P388D1 expression library. The nucleotide sequence of the cDNA is identical to that
of carbohydrate-binding protein 35, a galactose-specific lectin found in fibroblasts
and highly homologous to a rat IgE-binding protein from basophilicleukemia cells.
The in vitro synthesized Mac-2 protein displayed the expected carbohydrate- and
IgE-binding properties. By pulse-chase analysis and subcellular fractionation studies,
the Mac-2 protein was found in the cytosol but was also seen to accumulate in the
extracellular medium. The latter finding was surprising in view of the fact that the
cDNA did not encode a signal peptide or transmembrane domain. An alternatively
spliced cDNA with the potential to encode a NH2 terminally extended Mac-2 pro-
tein with a stretch ofhydrophobic amino acids at its NH2 terminus was also found,
but it is not clear whether it is the source of the extracellular Mac-2. Possible func-
tions for the Mac-2 protein based on its lectin- and IgE-binding properties are dis-
cussed.
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